FRED D. LUBLIN

机构：Icahn School of Medicine at Mount Sinai · ORCID：0000-0001-5722-0475

发表论文 432 篇 · 总被引 66970 次 · h-index 68

代表论文

• How patients with multiple sclerosis acquire disability (2022 · Brain · 被引 564)
• Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria (2025 · The Lancet Neurology · 被引 430)
• Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial (2022 · The Lancet Neurology · 被引 118)
• Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosis (2022 · Multiple Sclerosis Journal · 被引 46)
• AI-driven reclassification of multiple sclerosis progression (2025 · Nature Medicine · 被引 38)
• Advancing multiple sclerosis management in older adults (2025 · Nature Reviews Neurology · 被引 34)